Protocol Page


	Study ID (Protocol Number)
	CA209-017


	STUDY LOCATIONS*
	Chattanooga Oncology Hematology Associates Chattanooga, TN 37404 Recruiting	Duke University Medical Center Durham, NC 27710 Recruiting
	City Of Hope Duarte, CA 91010-3000 Recruiting	Fox Chase Cancer Center Philadelphia, PA 19111 Recruiting
	*Not all study site locations may be listed - please check back soon for updated information. For more information regarding other participating countries, please visit clinicaltrials.gov.

	STUDY NAME
	Study of BMS-936558 Compared to Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)
	STUDY OVERVIEW
	The purpose of the study is to compare the change in tumor size, and overall survival of BMS-936558 as compared with Docetaxel in subjects with squamous cell non-small cell lung cancer (NSCLC), after failure of prior platinum-based chemotherapy.

The study information provided here is a portion of what is available on ClinicalTrials.gov. Please visit ClinicalTrials.gov for complete information about this and other clinical studies.